Dräger acquires majority share of Swiss medical technology start-up “STIMIT”

Published:

Drägerwerk AG & Co. KGaA has acquired the majority share of STIMIT AG. With this acquisition, Dräger further expands its expertise in the field of lung-protective ventilation. STIMIT is specialized in lung activation and non-invasive stimulation of respiratory muscles in intensive care patients.

Read more about this news here.

Related articles

Recent articles